197 related articles for article (PubMed ID: 8391612)
21. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
22. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung.
Carey FA; Prasad US; Walker WS; Cameron EW; Lamb D; Bird CC
J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1214-7. PubMed ID: 1317930
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor.
Demir A; Gunluoglu MZ; Kara HV; Buyukpinarbasili N; Dincer SI
Thorac Cardiovasc Surg; 2008 Mar; 56(2):93-8. PubMed ID: 18278684
[TBL] [Abstract][Full Text] [Related]
25. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349
[TBL] [Abstract][Full Text] [Related]
26. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
[TBL] [Abstract][Full Text] [Related]
27. [Risk factors of recurrence in resected stage I non-small cell lung cancer].
Kita H; Koshiishi Y; Masui K; Fujita A; Ootsuka K; Furuyashiki G; Nakazato Y; Takei H; Goya T
Kyobu Geka; 2007 Sep; 60(10):883-7. PubMed ID: 17877005
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
29. Resection of chest wall invasion in patients with non-small cell lung cancer.
Matsuoka H; Nishio W; Okada M; Sakamoto T; Yoshimura M; Tsubota N
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1200-4. PubMed ID: 15541985
[TBL] [Abstract][Full Text] [Related]
30. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
[TBL] [Abstract][Full Text] [Related]
31. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
32. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
33. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
[TBL] [Abstract][Full Text] [Related]
35. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
36. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
37. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks.
Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Lange CM; Li H
Ann Thorac Surg; 1997 Nov; 64(5):1402-7; discussion 1407-8. PubMed ID: 9386711
[TBL] [Abstract][Full Text] [Related]
40. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]